Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2025-12-25 @ 3:57 AM
NCT ID:
NCT07157202
Eligibility Criteria:
Inclusion Criteria:
* Adult patients (aged ≥18 years) with a confirmed diagnosis of SLE according to the American College of Rheumatology (ACR) or Systemic Lupus International Collaborating Clinics (SLICC) classification criteria.
Patients who provide written informed consent to participate in the study. Patients who have not received antibiotics or proton pump inhibitors (PPIs) in the four weeks
Exclusion Criteria:
* Patients with a history of gastric surgery or known gastrointestinal malignancy.
* Patients currently receiving immunosuppressive therapy for conditions other than SLE.
* Patients with coexisting autoimmune diseases other than SLE.
* Pregnant or lactating women.
* Patients with active infections (other than H. pylori) at the time of enrollment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07157202
Study Brief:
Protocol Section:
NCT07157202